insulin glp-1 Schematic pathway showing release of by GLP-1. Binding of GLP-1 Agonists: Increasing Effective Insulin

Stay connected with news and updates

Better Blood Sugar Control For individuals with diabetes, these medications can be a game-changer

Personalized Plan Your provider develops a treatment plan that may include GLP-1 medications, dosage progression, and supportive lifestyle guidance

doi: 10.1016/S0140-6736(08)61246-5 36 HernandezAFGreenJBJanmohamedSD'AgostinoRBGrangerCBJonesNPet al

The critical path: TRIUMPH trials complete (Q2Q3 2026) Data analysis (34 months) NDA submission (Q4 2026 or Q1 2027) FDA review (610 months) Approval (late 2027 or Q1 2028) Launch preparation (13 months) Availability (Q1Q2 2028)

Taken together, these data make it clear that GLP-1 receptor agonists are here to stay as consumers continue to seek ways to manage their weight and cardiometabolic health, she says